Healthcare DIVE November 23, 2022
Centene inked a deal to sell Magellan Specialty Health for more than $750 million to Evolent Health.
It’s the latest divestiture in Centene’s plan to sell non-core assets as part of a long-term strategy to improve the company’s profit margin.
“This transaction is another significant milestone in our ongoing portfolio review and value creation plan,” CEO Sarah London said in a statement.
In July, Centene announced plans to sell its international assets to a private hospital operator in France. Centene is underway on a review of every unit within the company to determine whether it should remain.
Magellan Specialty Health, also known as NIA, provides utilization management services. The unit was previously...
Today's Sponsors
Today's Sponsor